Skip to main content

Table 2 Clinical, parasitological and other characteristics of patients in different major temporal patterns

From: Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children

 

aPattern 1

bPattern 2

cPattern 6

ALL

eP value

Number (%)

123 (49.6)

48 (19.4)

57 (23)

228 (92)

 

Gender

 M/F

66/57

21/27

33/24

120/108

0.33

Age (year)

 Mean (sd)

7.3 (3.6)

5.6 (2.7)

5.3 (2.7)

6.5 (3.3)

< 0.0001

 Range

0.7–14

2–10

1.2–12.5

0.7–14

 

Duration of illness (days)

 Mean (sd)

2.5 (1.1)

2.8 (1)

3.2 (1.3)

2.7 (1.2)

< 0.0001

 Range

1–7

1–5

1–7

1–7

 

Weight (kg)

 Mean (sd)

20.2 (7.5)

16.7 (5.3)

16.0 (4.3)

18.4 (6.7)

0.009

 Range

7–40

9–31

7–26

7–40

 

Haematocrit (%)

 Mean (sd)

34.7 (2.7)

32.4 (2.8)

26.4 (2.6)

32.3 (4.4)

< 0.0001

 Range

30–42

30–38

18–29

18–42

 

Temperature (°C)

 Mean (sd)

38.4 (1.1)

38.6 (1)

38.4 (1.2)

38.4 (1.1)

0.60

 Range

35–40.9

35–40.1

35.9–40.5

35–40.9

 

No. with temp.

 i. >37.4 °C (%)

97 (79)

42 (88)

43 (75)

182 (80)

0.28

 ii. >40.0 °C (%)

8 (7)

1 (2)

14 (25)

23 (10)

< 0.0001

Parasitaemia (μL−1)

 Geometric Mean

52,037

59,361

64,514

56,468

0.37

 Range

2,000-459,000

8,000-1,080,200

2,094-346,153

2,000-1,080,200

 

No. with ≥100,000 μL−1(%)

34 (27.6)

11 (22.9)

18 (31.6)

63 (27.6)

d0.61

  1. aHaematocrit ≥ 30 % before and following treatment
  2. bHaematocrit ≥ 30 % before treatment, two consecutive haematocrit < 30 % within 14 days of treatment, followed by a rise to ≥ 30 % [Early monophasic fall]
  3. cHaematocrit < 30 % before treatment, followed by a rise to ≥ 30 % after treatment [malaria-associated anaemia at presentation and recovery from anaemia]
  4. dChi-square test
  5. eP values quoted are for comparison across all three groups